LifeMD (NASDAQ:LFMD) Research Coverage Started at HC Wainwright

HC Wainwright began coverage on shares of LifeMD (NASDAQ:LFMD – Free Report) in a research report released on Monday morning, The Fly reports. The brokerage issued a buy rating and a $9.00 price objective on the stock. Separately, BTIG Research decreased their target price on LifeMD from $8.00 to $7.00 and set a buy rating […]

Related Keywords

United States ,Justin Schreiber ,Nicholasp Alvarez ,Geode Capital Management ,Lifemd Inc ,Renaissance Technologies ,Lifemd Company Profile ,Hightower Advisors ,Free Report ,Street Corp ,Capital Management ,Tower Advisors ,Jane Street Group ,Lifemd ,Nasdaq Lfmd ,Lfmd ,Medical ,Initiated Coverage ,Hc Wainwright ,